Articles Posted in Research Studies

Infographic-Type-1-Diabetes-232x300Critics are alarmed about a news article published on the front page of the New York Times and headlined: A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.

Really? We all fervently wish for a cure for the devastation of diabetes, especially type 1 which starts in childhood. But the problem, savvy readers found, is that the report falls far short of reasonable standards for a global news organization to trumpet the “c” wordcure.

Dig into the 2,000-word piece and skepticism should be the watch word. That’s because reporter Gina Kolata  focused on the earliest outcomes of a stem-cell treatment for type 1 diabetes undergoing clinical trials. So far, 17 patients have been treated. One patient, so far, has experienced positive results that have sustained for six months. The New York Times gave no clue about the outcomes for the 16 others.

aduhelm-300x250Taxpayers and patients are suffering the rising negative consequences of the federal Food and Drug Administration’s dubious decision to overrule its own independent expert advisors and to approve on scant evidence Aduhelm. It is a prescription drug targeting Alzheimer’s disease, and concerns are rising about the medication’s safety and costs, not to mention whether it really works.

FDA advisors had argued against the drug, cautioning  that it carries significant potential side effects including swelling and bleeding in the brain. Those taking Aduhelm have been warned to undergo frequent, regular, and pricey brain scans as safeguards.

Still, experts have been startled by a much-discussed death of a 75-year-old Canadian woman, who was taking the drug as part of a clinical trial. She suffered seizures, was hospitalized, had brain scans, and was diagnosed with brain swelling shortly before she died.

lotsapills-300x200The regular folks who make up juries may give more heed than judges and justices do to the how and why of patients’ push for justice in the civil system, as has been shown in yet another bellwether decision involving major drug store chains and claims they contributed to the nation’s worsening opioid abuse and drug overdose crisis.

CVS, Walgreens, and Walmart all contributed substantially to creating a public nuisance by failing to ask appropriate questions and flooding Lake and Trumbull, two Ohio counties, with countless numbers of prescription painkillers, 12 jurors in a Cleveland court found after a six-week trial and 5½ days of deliberation. As the New York Times reported of the lawyers for the plaintiff counties and their successful argument, the “first time the retail segment of the drug industry has been held accountable in the decades-long epidemic….”

“After hearings in the spring, the trial judge will determine how much each company should pay the counties. The verdict — the first from a jury in an opioid case — was encouraging to plaintiffs in thousands of lawsuits nationwide because they are all relying on the same legal strategy: that pharmaceutical companies contributed to a “public nuisance,” a claim that plaintiffs contend covers the public health crisis created by opioids. The public nuisance argument was rejected twice this month, by judges in California and Oklahoma in state cases against opioid manufacturers. The judges found that according to the specifics of their own states’ public nuisance laws, the companies’ activities were too removed from the overdoses and deaths and that the laws had been applied too expansively.

covidpic-300x247Americans’ Thanksgiving holiday traveling, socializing, and  shopping resumed with vigor, near pre-pandemic norms. And yet:

needles-300x152With studies showing that as many as half of patients infected with the coronavirus suffer physical and psychological problems for six months or more after they thought they first recovered, wise people may want to take every precaution they can against the disease.

They may wish to heed new federal recommendations calling for vaccine boosters, now approved for all Americans 18 and older and strongly encouraged for those older than 50.

The building data on “long Covid” is disconcerting, the Washington Post reported, noting:

kaiser21healthinsurancesurvey-300x204Most Americans get their health insurance through their jobs, and that coverage continues to increase in cost with the average annual premiums in 2021 exceeding $22,200 for families and $7,700 for individuals — a 4% rise from 2020.

The price increases affecting 155 million non-elderly people with employer-provided coverage, as detailed in the annual Kaiser Family Foundation surve, may seem modest, year over year, especially given that conventional wisdom saw all health care costs hit hard by the coronavirus pandemic.

But the foundation notes that overall health coverage costs, borne by employers and their workers, have not spiked due to the coronavirus, though they have risen relentlessly over a decade (see figure, above).

bowserbooster-300x225The coronavirus pandemic continues to kill an average of 1,200 Americans each day and the disease infects more than 76,000 people daily — unwavering numbers that have led public health officials — wary of what the hectic holidays will bring — to double down on their campaign for vaccinations against the virus.

This is especially true for kids, and with boosters, perhaps now for almost all.

The drug maker Pfizer, which already had presented federal regulators with data on how its vaccine wanes in effectiveness over time, has asked for approval to give all patients who have completed its two-shot regimen a third dose for increased protection.

debt-300x200Soaring medical costs crush the finances of far too many patients, as the public was reminded by the release of an annual report on the high toll of cancer-care spending and a surprising congressional reverse aimed at reining in runaway prescription drug prices — or at least attempting to.

Leading organizations dealing with cancer treatment — including the American Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries — found that patients in 2019 (the most recent year data were available) “shouldered a whopping $21.09 billion in costs,” the Washington Post reported.

Patients and their loved ones get hit with major costs in the first year of disease diagnosis, as well as the highest expenses at the ill individuals’ end of life, the report found.

dcautowreck32821wusa-300x1942021 has become a torment for the safety of the nation’s roads, as the country between January and June hit its largest six-month percentage increase in fatalities in the half-century U.S. officials have kept such records.

In the first half of ‘21, 20,160 people died in vehicle wrecks — an 18.4% increase over the comparable period in the year before.

That six-month vehicular death toll, which only now is becoming official, also was the highest recorded in 15 years.

cnncovidicu-300x242When hospitals too often fail to disclose and to adequately deal with their problems, patients and their loved ones suffer. That’s what happened during the coronavirus pandemic, when individuals admitted for other reasons were infected in hospitals and died of Covid-19 at alarming rates.

The federal government, separately, also is stepping up its efforts to get hospitals to comply with U.S. regulations to foster greater transparency in institutions’ pricing of medical goods and services.

The independent, nonpartisan Kaiser Health News (KHN) service, to its credit, has dug into publicly available data to show how Covid-19 became the latest problem pathogen spread in hospitals — part of the menace long known as HAIs or hospital acquired infections.

Patrick Malone & Associates, P.C. listed in Best Lawyers Rated by Super Lawyers Patrick A. Malone
Washingtonian Top Lawyer 2011
Avvo Rating 10.0 Superb Top Attorney Best Lawyers Firm
Contact Information